CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-02 | Garg Vipin K President and CEO | Shares withheld for taxes | −8,376 | $9.32 | $78K | 292,028 |
| 2024-02-02 | Garg Vipin K President and CEO | Option exercise · Restricted Stock Units | −18,950 | 37,900 | ||
| 2024-02-01 | Roberts M Scot Chief Scientific Officer | Option exercise | +6,166 | 39,016 | ||
| 2024-02-01 | Roberts M Scot Chief Scientific Officer | Shares withheld for taxes | −1,801 | $9.88 | $18K | 37,215 |
| 2024-02-01 | Roberts M Scot Chief Scientific Officer | Option exercise · Restricted Stock Units | −6,166 | 6,166 | ||
| 2024-02-01 | Harris Matthew Scott Chief Medical Officer | Option exercise | +6,166 | 49,991 | ||
| 2024-02-01 | Harris Matthew Scott Chief Medical Officer | Shares withheld for taxes | −1,801 | $9.88 | $18K | 48,190 |
| 2024-02-01 | Harris Matthew Scott Chief Medical Officer | Option exercise · Restricted Stock Units | −6,166 | 6,166 | ||
| 2024-02-01 | Garg Vipin K President and CEO | Option exercise | +16,545 | 288,767 | ||
| 2024-02-01 | Garg Vipin K President and CEO | Shares withheld for taxes | −7,313 | $9.88 | $72K | 281,454 |
| 2024-02-01 | Garg Vipin K President and CEO | Option exercise · Restricted Stock Units | −16,545 | 16,545 | ||
| 2024-01-31 | Roberts M Scot Chief Scientific Officer | Grant or award | +5,860 | $2.69 | $16K | 32,850 |
| 2024-01-31 | Jordt Raymond M Chief Business Officer | Grant or award | +5,030 | $2.69 | $14K | 13,743 |
| 2024-01-31 | Harris Matthew Scott Chief Medical Officer | Grant or award | +3,257 | $2.69 | $9K | 43,825 |
| 2024-01-31 | Garg Vipin K President and CEO | Grant or award | +7,889 | $2.69 | $21K | 272,222 |
| 2024-01-31 | Eisenstadt Richard I Chief Financial Officer | Grant or award | +4,621 | $2.69 | $12K | 45,012 |
| 2024-01-30 | Roberts M Scot Chief Scientific Officer | Option exercise | +9,275 | 29,699 | ||
| 2024-01-30 | Roberts M Scot Chief Scientific Officer | Shares withheld for taxes | −2,709 | $9.80 | $27K | 26,990 |
| 2024-01-30 | Roberts M Scot Chief Scientific Officer | Option exercise · Restricted Stock Units | −9,275 | 27,825 | ||
| 2024-01-30 | Harris Matthew Scott Chief Medical Officer | Option exercise | +9,275 | 43,277 |
Page 10 of 29 · 568 trades